Pulse Biosciences, Inc., a bioelectric medicine company progressing Nano-Pulse Stimulation (NPS) technology, has announced that clinical results from studies spanning the company’s dermatologic application portfolio will be presented at the American Society for Dermatologic Surgery (ASDS) virtual annual meeting on October 9 – 11, 2020. Positive study results generated using the company’s cellular-specific NPS mechanism performed with its CellFX System for the treatment of sebaceous hyperplasia lesions, cutaneous non-genital warts, plantar warts and basal cell carcinoma will be presented in two oral presentations and two e-posters.
Read more at Business Wire >>